pharma
Biotest Farmaceutica Ltda
Biotest Pharma GmbH
Biotest Farmaceutica Ltda patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- Dreieich, DE
- Employees
- 2
- Programs
- 1
- Drugs
- 5
- Patents
- 4
Biotest Farmaceutica Ltda patents
4 pharmaceutical patents indexed for Biotest Farmaceutica Ltda. 0 expire within 24 months.
Biotest Farmaceutica Ltda has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
CA 1341505
PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION
expired -
DK 0781560
Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
expired -
AT E191006
MENSCHLICHE MONOKLONALE ANTIKÖRPER GEGEN RHESUS D UND ZELLINIEN DIE DIESE PRODUZIEREN
expired -
DE 69229278
HUMANISIERTER B-B10, EIN ANTI-IL-2-REZEPTOR-ANTIKÖRPER
expired
Frequently asked questions
How many patents does Biotest Farmaceutica Ltda have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Biotest Farmaceutica Ltda patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.